Compare FDMT & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDMT | MITK |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 723.9M |
| IPO Year | 2019 | 1995 |
| Metric | FDMT | MITK |
|---|---|---|
| Price | $10.38 | $17.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $31.71 | $15.00 |
| AVG Volume (30 Days) | 794.2K | ★ 812.5K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.79 | ★ 171.43 |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $85,209,000.00 | $45,390,000.00 |
| Revenue This Year | N/A | $9.55 |
| Revenue Next Year | $70.28 | $8.07 |
| P/E Ratio | ★ N/A | $67.48 |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $4.27 | $8.53 |
| 52 Week High | $14.00 | $21.05 |
| Indicator | FDMT | MITK |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 43.51 |
| Support Level | $9.71 | $13.15 |
| Resistance Level | $10.50 | $17.97 |
| Average True Range (ATR) | 0.79 | 0.91 |
| MACD | -0.30 | -0.41 |
| Stochastic Oscillator | 10.76 | 32.16 |
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.